Panoutsopoulou K, Avgeris M, Magkou P, Mavridis K, et al. miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients. Int J Cancer 2020 Jul 4. doi: 10.1002/ijc.33182.
PMID: 32621752